Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sensitive detection of DNA methylation.

Susan E Cottrell1, Peter W Laird

  • 1Epigenomics, Inc., Seattle, Washington 98101, USA.

Annals of the New York Academy of Sciences
|May 2, 2003
PubMed
Summary

DNA methylation markers offer sensitive and specific tumor detection, crucial for early cancer diagnosis. Advances in PCR-based assays enhance their clinical utility for identifying neoplastic lesions in various body fluids.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genome-wide profiling of unmodified DNA using methyltransferase-directed tagging and enrichment.

Cell reports methods·2025
Same author

High-coverage allele-resolved single-cell DNA methylation profiling reveals cell lineage, X-inactivation state, and replication dynamics.

Nature communications·2025
Same author

Pan-cancer immune and stromal deconvolution predicts clinical outcomes and mutation profiles.

Scientific reports·2025
Same author

Three-dimensional genome landscape of primary human cancers.

Nature genetics·2025
Same author

Protocol for obtaining cancer type and subtype predictions using subSCOPE.

STAR protocols·2025
Same author

Protocol for assessing distances in pathway space for classifier feature sets from machine learning methods.

STAR protocols·2025

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Oncology

Background:

  • Molecular biomarkers are vital for distinguishing tumors from normal tissue.
  • DNA methylation markers offer a unique combination of specificity, sensitivity, and high information content.
  • These markers are applicable to various clinical specimens, especially when tumor DNA is scarce or diluted.

Purpose of the Study:

  • To highlight the potential of DNA methylation markers for sensitive tumor detection.
  • To discuss the role of methylation-specific PCR (MSP) and fluorogenic probes in quantitative methylation analysis.
  • To explore the application of PCR-based methylation assays in detecting tumor DNA in body fluids for early cancer diagnosis.

Main Methods:

  • Methylation-specific PCR (MSP) for measuring DNA methylation levels.
  • Fluorogenic probe-based assays for enhanced informativeness and quantification.
  • Discussion of alternative methylation-sensitive amplification techniques.
  • Application of PCR-based assays to detect tumor DNA in serum, plasma, urine, sputum, and lavage fluids.

Main Results:

  • Methylation markers demonstrate high sensitivity and specificity in detecting tumor DNA in various body fluids.
  • Fluorogenic probe addition improves assay informativeness, quantification, and clinical suitability.
  • PCR-based methylation assays have shown impressive sensitivity and specificity in numerous studies.

Conclusions:

  • DNA methylation markers are powerful tools for sensitive and specific tumor detection.
  • Further technological advancements in sample preparation, assay design, and marker selection are needed.
  • Addressing these technical concerns will establish sensitive methylation detection as a key diagnostic and prognostic tool for early cancer detection.

Related Experiment Videos